Sentence examples for trial failure from inspiring English sources
The causes of extubation failure are different of those of spontaneous ventilation trial failure.
Clinically, it would also provide inclusion/exclusion criteria by identifying subjects with desired graft distributions, assisting with interpretation of trial failure or success.
Ignorance of these pitfalls directly affects the quality of the imaging read-out, leading to trial failure, particularly when imaging is a primary endpoint.
We see more than 70% upside to our revised target price [down from 450p to 160p] post the Phase 3 allergy trial failure but acknowledge the uncertainty overhang medium-term unless a strategic bid emerges.
Analysts at Peel Hunt said: We see more than 70% upside to our revised target price [down from 450p to 160p] post the Phase 3 allergy trial failure but acknowledge the uncertainty overhang medium-term unless a strategic bid emerges.
That court also held that the prisoner's demand upon the accusing State gives rise to an obligation to act affirmatively to secure his presence for trial; failure of the accusing State to promptly obtain the defendant from the detaining sovereign might invalidate any judgment ultimately obtained, if the time lapse is sufficiently great and is not excused.
At present, the clinical trial failures in OA may be a consequence of both bona fide treatment failures and trial failures due to clinical design deficiencies.
It has resulted in numerous clinical trial failures and high drug development costs.
Over the past decade, the rate of drug attrition due to clinical trial failures has risen substantially.
And a series of studies scheduled for Monday may shed light on the recent trial failures of promising drugs from Pfizer and AtheroGenics that doctors had hoped would reduce the buildup of dangerous plaque in coronary arteries.
AstraZeneca has recruited its new chief executive, Pascal Soriot, from Roche Holding, hoping his experience with biotechnology drugs and deal-making can revive a company battered by clinical trial failures and patent expirations.
